Antiangiogenic Drugs for Chemotherapy of Bladder Tumours

Publisher： Karger

E-ISSN： 1421-9794|51|6|291-299

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.6, 2005-11, pp. : 291-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma

By Ribatti Domenico  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1225-1231

MDPI

Access to resources Recommend Favorite

Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy

By Kunze Doreen   Erdmann Kati   Froehner Michael   Wirth Manfred P.   Fuessel Susanne  

International Journal of Molecular Sciences, Vol. 14, Iss. 6, 2013-06 ,pp. : 12297-12312

MDPI

Access to resources Recommend Favorite

Antiepileptic Drugs Reduce the Efficacy of Methotrexate Chemotherapy through Accelerated Degradation of the Reduced Folate Carrier by the Ubiquitin-Proteasome Pathway

By  

Chemotherapy, Vol. 57, Iss. 4, 2011-09 ,pp. : 345-356

Karger

Access to resources Recommend Favorite

Antiangiogenic Effect of Flavonoids and Chalcones: An Update

By Mirossay Ladislav   Varinská Lenka   Mojžiš Ján  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 27-27

MDPI

Access to resources Recommend Favorite

Biomarkers for Anti-Angiogenic Therapy in Cancer

By Wehland Markus   Bauer Johann   Magnusson Nils E.   Infanger Manfred   Grimm Daniela  

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-04 ,pp. : 9338-9364

MDPI

Access to resources Recommend Favorite